Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 24, Issue 3, 2001, Pages 165-185

  Tarello, W ^a  

^a NONE   (Italy)

Author keywords

Arsenic; Cat; Chronic fatigue syndrome (CFS); Dog; Fatigue; Micrococci; Muscular diseases; Staphilococcus; Thiacetarsamide sodium; Zoonosis

Indexed keywords

AMOXICILLIN; ARSENIC DERIVATIVE; CEFALEXIN; CHLORAMPHENICOL; KANAMYCIN; OFLOXACIN; STREPTOMYCIN; THIACETARSAMIDE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BIOCHEMISTRY; BLOOD CULTURE; BLOOD SMEAR; CHRONIC FATIGUE SYNDROME; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; HUMAN; MICROBIOLOGY; MICROCOCCUS; MYOPATHY; NONHUMAN; REMISSION; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS INTERMEDIUS; STAPHYLOCOCCUS XYLOSUS; SYMPTOM; TREATMENT OUTCOME;

ANIMALS; ARSENAMIDE; CAT DISEASES; CATS; CREATINE KINASE; DOG DISEASES; DOGS; FATIGUE SYNDROME, CHRONIC; MAGNESIUM; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

ANIMALIA; CANIS FAMILIARIS; FELIS CATUS;

EID: 0034973320     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9571(00)00025-4     Document Type: Article

References (92)

1. Arsenic-induced apoptosis in malignant cells in vitro
2. 3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages
3. Effects of staphylococcus toxoid vaccine on pain and fatigue in patients with fibromyalgia/chronic fatigue syndrome
4. Post-viral fatigue syndrome. Persistence of enterovirus RNA in muscle and elevated creatine kinase
5. Clinical laboratory test findings in patients with chronic fatigue syndrome
6. Neurasthenia, or nervous exhaustion
7. The effects of As (III) and As (V) on the batch bioleaching of a pyrite-arsenopyrite concentrate
8. Episodic weakness associated with exertional lactic acidosis and myopathy in Old English Sheepdog littermates
9. Immunodeficiency and infectious diseases
10. A chronic illness characterized by fatigue, neurologic and immunologic disorders and active human herpes virus type 6 infection
11. Interpretation of laboratory results for small animal clinicians
12. An association of membrane damaging toxins from coagulase negative staphylococci and chronic orofacial muscle pain
13. The treatment of CFS: The clinical and scientific basis of chronic fatigue syndrome: From myth towards management
14. Interleukin-2 and the chronic fatigue syndrome
15. Domestic animal illness associated with CFIDS
16. Intravenous magnesium loading in chronic fatigue syndrome
17. 3+ to male Winstar rats
18. Red blood cell magnesium and chronic fatigue syndrome
19. The partial passing of neurasthenia
20. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America
21. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci
22. Biochemical and microbiological anomalies in Chronic Fatigue Syndrome: The development of laboratory based tests and the possible role of toxic chemicals
23. Chronic Fatigue Syndrome and chronic primary magnesium deficiency
24. Urinary excretion of arsenic and its metabolites in a population of adult males not occupationally exposed in the province of Bari
25. The chronic fatigue syndrome: A comprehensive approach to its definition and study
26. Emerging antibiotic-resistant bacteria. Their treatment in the total joint arthroplasty
27. The human/animal interaction of Chronic Fatigue and Immune Dysfunction Syndrome: A look at 127 patients and their 463 animals
28. Neurasthenia in the 1980s: Chronic mononucleosis, chronic fatigue syndrome, anxiety and depressive disorders
29. A colour atlas of comparative veterinary haematology
30. Staphylococcal enterotoxin microbial superantigens
31. Magnesium and chronic fatigue syndrome
32. Long term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As203: An experience of 120 patients at a single institution
33. Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases
34. Patologia speciale e terapia degli animali domestici
35. Arsenic trioxide inhibits growth of human T-cell leukaemia virus type I infected T-cell lines more effectively than retinoic acids
36. Paul Ehrlich: Pathfinder in cell biology. 1. Chronicle of his life and accomplishments in Immunology, Cancer, and Chemotherapy
37. Distribution of Staphilococcus xilosus species among human clinical specimens and emended description
38. Infection in elderly leukemic patients
39. Genus Staphilococcus
40. IgG subclasses deficiencies in chronic fatigue syndrome
41. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines
42. Novel therapeutic approach: Organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo
43. Feline ataxia due to non-suppurative meningoencephalomyelitis of unknown aetiology
44. Effect of arsenic exposure on alveolar macrophage function I. Effects of soluble As(III) and As(V)
45. Effect of arsenic exposure on alveolar macrophage function. II. Effect of slightly soluble forms of As(III) and As(V)
46. Toxic shock syndrome toxin-secreting Staphilococcus aureus in Kawasaki syndrome
47. Arsenic trioxide causes selective necrosis in solide murine tumours by vascular shutdown
48. A double-blind, placebo-controlled trial of intravenous immunoglobulins therapy in patients with chronic fatigue syndrome
49. Effects of sulphur-arsenic-ferrous water treatment on specific chronic phlogosis of the upper respiratory tract
50. Antibiotic resistance of coagulase-negative staphylococci isolated from artisanal Naples-type salami
51. Seroepidemiology of chronic fatigue syndrome-a case control study
52. Les hémocultures
53. Preliminary determination of the association between symptom expression and urinary metabolites in subjects with Chronic Fatigue Syndrome
54. Toxic coagulase negative staphilococci are associated with changes in urinary organic and amino acid excretion in chronic facial muscle pain patients. The clinical and scientific basis of Chronic Fatigue Syndrome: Management
55. Host verses acquired responses in Chronic Fatigue Disorders. The clinical and scientific basis of Chronic Fatigue Syndrome: From myth towards management
56. Miopatie (Capitolo 73)
57. Information for physicians
58. What really killed Gilda Radner?
59. Fifty things you should know about the Chronic Fatigue Syndrome epidemic
60. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress
61. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome
62. Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome
63. Equine fatigue syndrome
64. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients
65. A cura della Bayer veterinaria
66. The use of arsenic in various respiratory diseases
67. Effects of As-deficiency on skeletal muscle, myocardium and liver
68. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-!
69. Arsenic trioxide induces apoptosis on oesophageal carcinoma in vitro
70. Nozioni di Farmacologia e farmacoterapia veterinaria
71. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
72. Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia
73. Idiopathic non-suppurative meningo-encephalo-myelitis (staggering disease) in the Swedish cat: A study of 33 cases
74. A case of chronic fatigue syndrome who showed a beneficial effect by intravenous administration of magnesium
75. Chronic Fatigue Syndrome in horses: Diagnosis and treatment of 4 cases
76. Increasing bacteremia due to coagulase-negative staphylococci: Fiction or reality?
77. Arsenic essentiality and factors affecting its importance
78. Sodium arsenite reduces proliferation of human activated T-cell by inhibition of the secretion of interleukin-2
79. Human herpesviruses in chronic fatigue syndrome
80. Old wine in new bottles: Neurasthenia and ME
81. Natural killer cells and natural killer cell activity in chronic fatigue syndrome
82. Diagnostica clinica dei piccoli animali e referti di laboratorio
83. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide
84. Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression
85. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations